KAETI MEISNER: Open Payments
NPI 1619419470 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 47 payments from 20 companies in 2025. Trend: 2023 $1,477 · 2024 $966 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $183 |
| Novartis Pharmaceuticals Corporation | 5 | $133 |
| ABBVIE INC. | 5 | $106 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| PFIZER INC. | 3 | $70 |
| Daiichi Sankyo Inc. | 3 | $69 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| BeOne Medicines USA, Inc. | 2 | $38 |
| ARRAY BIOPHARMA INC | 2 | $35 |
| Eisai Inc. | 1 | $26 |
Products named: IMFINZI, Fabhalta, CALQUENCE, Enhertu, RINVOQ, OPDIVO, SKYRIZI, KEYTRUDA.
Industry payments across AL — which companies pay providers there.
